|
Category: Drug & Medical Device Innovation
The increasingly important role of prescription medicines as both complements to and substitutes for other medical procedures,
as well as rising costs for newer and more effective medicines, has precipitated an array of proposals for reducing private and public spending on
drugs. Some prominent observers have even questioned whether the current system of research and development is as cost-effective as alternatives
might be, and, in particular, whether the central role of private pharmaceutical firms in drug research and development produces commensurate
social benefits.
However, the enormous risk and costs of bringing new products to market means that many medical innovations would not be
developed without substantial private sector investment and research. The Center for Medical Progress seeks to chronicle the gains in health and
longevity associated with both basic and clinical research, the arduous struggle to move products from the lab bench to the bedside, and effective
public policies that encourage both development of and widespread access to new medicines.
[Spotlight] [Commentary] [Research] [Events] [News]
Spotlight
- Regulation's Impact On Innovation: A Two-Edged Sword Rita E. Numerof, Ph.D., 5-15-09
- Big Pharma Can Save Us Paul Howard, 5-1-09
- Lessons learned from a last battle Jeff Stier, JD, 11-21-08
- Drug Development Needs Private Industry Benjamin Zycher, Ph.D., 6-28-08
- The Truth About Drug Innovation: Thirty-Five Summary Case Histories on Private Sector Contributions to Pharmaceutical Science Benjamin Zycher, Ph.D., , Christopher-Paul Milne, , Joseph DiMasi, Ph.D., 6-27-08
- Patently Obvious Philip Stevens, , Paul Howard, Ph.D., 4-17-08
- The Science and Economics of Cholesterol Drugs Gilbert L. Ross, M.D., 1-18-08
Commentary
- Critical Diagnosis, Tomas Philipson and Paul Howard, Forbes.com, 2-3-10
- Hello Health, Goodbye Hassle, Paul Howard, City Journal Online, 1-13-10
- Science on the Potomac, Peter Huber, Forbes, 1-6-10
- Washington's Gift to European Biotech, Benedetto Della Vedova, Wall Street Journal, 11-14-09
- Health reform must promote innovation, Ken Johnson, Politico, 11-2-09
- What We Would Have Told Obama, DONALD J. PALMISANO, WILLIAM G. PLESTED II AND DANIEL H. JOHNSON JR., Wall Street Journal, 10-5-09
- The Pharmaceutical Umbrella, Benjamin Plotinsky, City Journal Online, 9-22-09
- To Explain Longevity Gap, Look Past Health System, John Tierney, New York Times, 9-22-09
- Retail Health Care and Reform, Ed Morrissey, American Issues Project, 9-3-09
- The End of Medical Miracles?, Tevi Troy, Wall Street Journal, 6-1-09
- Prescription For E-Health Care, Forbes, 5-25-09
- Health-Care Reform and the 'Innovation Test', JOHN C. LECHLEITER, Wall Street Journal, 5-14-09
- Specter On Cancer, Wall Street Journal editorial, 5-5-09
- Cancer Patients Deserve Faster Access to Life-Saving Drugs, Richard A. Epstein, Wall Street Journal, 5-3-09
- "GPS" for Health Care, Paul Howard and Gualberto Ruano, City Journal Online, 4-15-09
- Going To Church, Matthew Herper, Forbes, 4-13-09
- Uncle Sam, Tech Investor, Peter Huber, Forbes Magazine
- Hope for Ending Alzheimer's, Human Events, 4-1-09
- Bad Bet on Medical Records, Stephen B. Soumerai and Sumit R. Majumdar, Washington Post, 3-17-09
- Stem Cells and the Truth About Medical Innovation, Scott Gottlieb, Wall Street Journal, 3-13-09
- Blocking drug development, Dr. Gilbert Ross, Washington Times, 3-13-09
- Sweden's Government Health Care, Walter Williams, Townhall.com
- Getting it right with modern drugs, Peter Pitts and Robert Goldberg, Washington Times, 3-2-09
- The Next Front in the War on Cancer, Mark Thorton, Wall Street Journal, 2-27-09
- My Drug Problem, Virginia Postrel, The Atlantic, March 2009
- A Health-Tech Monopoly, Wall Street Journal, editorial, 2-11-09
- Don't stifle private ingenuity, Grace-Marie Turner, Philadelphia Inquirer, 1-26-09
- Medicine's Miracle Man, John E. Calfee, The American, 1-23-09
- The High and Low Tech of Health Care Innovation, Abigail Zuger, New York Times, 12-29-08
Research
- Shackling Innovation: The Regulation of Industry-Supported Clinical Trials, Sigrid Fry-Revere, Alison Mathey, David Malmstrom, Competitive Enterprise Institute, February 2010
- Retail Clinics: Convenient and Affordable Care, Devon Herrick, National Center for Policy Analysis, 1-14-10
- Hospital Computing and the Costs and Quality of Care: A, David U. Himmelstein, Adam Wright, and Steffie Woolhandler, American Journal of Medicine, November 2009
- Bending the Productivity Curve Why America Leads the World in Medical Innovation, Glen Whitman and Raymond Raad, Cato Institute, 11-18-09
- Prostate Cancer: From Inoperable to Cancer Free, Mayo Clinic
- Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption, Anupam Jena, Tomas Philipson, National Bureau of Economic Research, 6-9-09
- Calculating the return on investment of mobile healthcare, Biomed Central, 6-2-09
- U.S. Markets for Vaccines, Ernst R. Berndt, Rena N. Denoncourt, Anjli C. Warner, American Enterprise Institute, 5-1-09
- Pharmaceutical Evolution: The Advantages of Incremental Innovation in Drug Development, Albert I. Wertheimer and Thomas M. Santella, Competitive Enterprise Institute, April 2009
- ENTREPRENEURS FOR CURES: The Critical Need for Innovative Approaches to Disease Research, Faster Cures
- The Value of Innovation in Health Care, Galen Institute, 1-9-09
- How Obama Would Stifle Drug Innovation, Scott Gottleib, American Enterprise Institute, 11-7-08
- The Ability of Various Measures of Fatness to Predict Application for Disability Insurance, Richard Burkhauser, John H. Cawley, Maximilian Schmeiser, American Enterprise Institute, 10-24-08
- The Stealth Mental Health Parity Act: An Attack on Innovation and Choice in Health Care, John R. Graham, Pacific Research Institute, 10-17-08
News
- Most Drug Studies Don't Help Docs Pick Best Treatment, Business Week, 3-10-10
- Billy Tauzin to step down from PhRMA, Politico, 2-12-10
- Innovations in Delivering Health Care, Wall Street Journal, 10-27-09
- US health reforms will raise prices of breakthrough drugs, PharmaTimes, 9-2-09
- Study traces steady declines in U.S. cancer deaths, Reuters, 8-13-09
- 14 Medical Pioneers Who Aren't Holding Back, U.S News & World Report, 7-2-09
- Health system discourages innovation, Reauters, 5-28-09
- Falling U.S. cancer rate saves 650,000 lives: report, Reuters, 5-28-09
- Virus Tamed To Destroy Cancer Cells But Leave Healthy Cells Unharmed, Science Daily, 5-26-09
- Trial drugs 'reverse' Alzheimer's, BBC News, 5-7-09
- Japanese scientist claims breakthrough with organ grown in sheep, The Times, 5-5-09
- Advances Elusive in the Long Drive to Cure Cancer, New York Times, 4-24-09
- What's Up, Doc?, Good Magazine, 4-21-09
- One speck of blood or tissue may be enough to diagnose cancer, London Times, 4-13-09
- Heart-Disease Research Comes Amid Drug-Industry Woes, Wall Street Journal, 3-24-09
- The Fight To Keep Genentech's Genius, Forbes, 3-16-09
- Cash Dries Up for Biotech Drug Firms, Wall Street Journal, 3-16-09
- Wyeth v. Levine May Affect Device Litigation, Notwithstanding Riegel v. Medtronic, InVivo Blog, 3-12-09
- Japanese Researchers Develop New Smallpox Vaccine, MedlinePlus, 3-11-09
- Wal-Mart plans to market digital health records system, International Herald Tribune, 3-11-09
- Experts use nanotech to deliver anti-cancer genes, Reuters, 3-10-09
- Google Health Enables Sharing Health Records, Information Week, 3-5-09
- Laser therapy promising for smaller strokes, MSNBC, 2-20-09
- Molecule's Prevalence May Aid in Deciding Whether to Treat Prostate Cancer, Washington Post, 2-17-09
|
|
MPT on Twitter
MPT on Facebook
